Gimcheon, South Korea

Hyung Geun Baek

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2001.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hyung Geun Baek. Retrieved from https://idiyas.com/inventor/hyung-geun-baek

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,601 
Other
 patents

Years Active: 2001

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Hyung Geun Baek in Anti-Cancer Research.

Introduction

Hyung Geun Baek is a notable inventor based in Kimcheon, South Korea. He has made significant contributions to the field of anti-cancer research through his innovative work on thymol derivatives.

Latest Patents

Hyung Geun Baek holds a patent for "Thymol derivatives having anti-tumor activity, and anti-cancer agent comprising the same." This invention relates to a thymol derivative represented by a specific chemical formula, along with its pharmaceutically acceptable salts or esters. The active ingredient in this patent serves as an anti-cancer agent, showcasing Baek's commitment to advancing cancer treatment.

Career Highlights

Throughout his career, Baek has focused on developing pharmaceutical solutions that target cancer cells. His research has led to the creation of effective compounds that have the potential to improve patient outcomes in cancer therapy.

Collaborations

Hyung Geun Baek has worked alongside talented colleagues, including Ok Pyo Zee and Young Hoon Jung. Their collaborative efforts have contributed to the advancement of research in the field of oncology.

Conclusion

Hyung Geun Baek's innovative work in developing anti-cancer agents highlights his dedication to improving healthcare through scientific research. His contributions are paving the way for future advancements in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…